Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders To Inquire About Securities Fraud Class Action

Core Viewpoint - A securities fraud class action lawsuit has been filed against Jasper Therapeutics, Inc. on behalf of investors who acquired its securities during the specified class period [1] Group 1 - The lawsuit is initiated by Glancy Prongay & Murray LLP, a prominent national shareholder rights law firm [1] - The class period for the lawsuit is defined as from November 30, 2023, to July 3, 2025 [1] - Investors have until November 18, 2025, to file a lead plaintiff motion [1]